MedPath

Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease

Not Applicable
Conditions
Behcet Syndrome
Autoimmune
Interventions
Radiation: Diode laser 980nm&100 mWatt
Registration Number
NCT03771768
Lead Sponsor
Cairo University
Brief Summary

Laser therapy is increasingly showing promising results in dental field including oral ulcers.This trial will assess the usefulness of Diode Laser compared to corticosteroid on oral ulcers of patients diagnosed with Behcet's disease.

Detailed Description

The enrolled patients will be divided randomly into two groups.one group will receive Diode Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide 0.1% 5 gram adhesive paste - Dermaphor) four times daily.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
38
Inclusion Criteria
  • patients diagnosed with Behcet's Disease according to International Criteria for BD.
  • patients with active oral ulcers.
  • patients free from any visible oral lesions other than the oral ulcers of BD.
  • patients who agreed to take the supplied interventions.
  • patients who will agree to participate in the study.
  • patients who will accept to sign the informed consent.
Exclusion Criteria
  • patients not physically able to participate in survey or clinical oral examination.
  • patients with organ or life-threatening disease.
  • patients with history of a severe or chronic medical condition including tuberculosis, hepatitis and human immunodeficiency virus.
  • patients under immunosuppressive drugs.
  • patients with organ transplantation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diode laserDiode laser 980nm&100 mWattDiode laser 980 nm \& 100mWatt.
Triamcinolone acetonideTriamcinolone AcetonideTriamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1 month.
Primary Outcome Measures
NameTimeMethod
Oral ulcer activity indexOne month

Composite index score (0-10)

Secondary Outcome Measures
NameTimeMethod
Pain associated with oral ulcerOne month

Visual analogue scale (0-10)

Oral health - related quality of lifeOne month

Oral health impact profile - 14 (OHIP- 14)

© Copyright 2025. All Rights Reserved by MedPath